Stock GHDN BRAINSTORM CELL THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Brainstorm Cell Therapeutics Inc. Deutsche Boerse AG

Equities

GHDN

US10501E2019

Delayed Deutsche Boerse AG
Other stock markets
 06:17:25 2024-04-30 am EDT 		5-day change 1st Jan Change
0.465 EUR -5.01% Intraday chart for Brainstorm Cell Therapeutics Inc. -6.44% +102.17%
Apr. 17 Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 CI
Apr. 17 Brainstorm Cell Therapeutics Inc. Announces Management Changes CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Downgrades Brainstorm Cell Therapeutics to Hold From Buy
MT
Fed rates at 7%: Is it on the cards?
Our Logo
Maxim Group Adjusts Price Target on Brainstorm Cell Therapeutics to $10 From $5, Maintains Buy Rating
MT
BRAINSTORM CELL THERAPEUTICS : Maxim Group Upgrades Brainstorm Cell Therapeutics to Buy From Hold
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BCLI Stock
  4. GHDN Stock
  5. News Brainstorm Cell Therapeutics Inc.
  6. Analyst Reco.